**About the Editors**

**Joris C Verster** (1970) studied psychology and obtained his Ph.D. at the Utrecht Institute for Pharmaceutical Sciences in 2002. Verster is Associate Professor at the Division of Pharmacology at Utrecht University, The Netherlands, and Adjunct Professor of Human Psychopharmacology at the Centre for Human Psychopharmacology of Swinburne University of Technology, Melbourne, Australia. Dr. Verster investigates the impact of exposome pressure (e.g., lifestyle factors) on health, immune fitness, and behavior. The aim of this multidisciplinary research is to develop and implement tools and methods (biomarkers, clinical assessments, and questionnaires), and to collect real world evidence on how a wide range of environmental factors may impact health outcomes and quality of life. Dr. Verster has a track record of clinical trials examining the effects of CNS drugs and psychoactive substances on cognitive and psychomotor functioning, mood, sleep, and daily activities, such as driving a car. He conducts extensive research into the effects of alcohol use as risk factor in health and disease, and the causes, consequences, and treatments of an alcohol hangover. Verster is the founder of the Alcohol Hangover Research Group, and his research is regularly covered by international media. Joris serves as scientific advisor for both industry and governmental organizations.

**Lizanne Arnoldy** is a Ph.D. candidate from the Centre for Human Psychopharmacology at Swinburne University, where she explores the role of diet on aging brains, as indexed by diffusion weighted imaging. Arnoldy has a background in pharmacy, and previously worked for Utrecht University where she conducted research for the World Health Organization.

**Sarah Benson** is a Postdoctoral Research Fellow at the Centre for Human Psychopharmacology, Swinburne University. She completed her Ph.D. in 2016, where she explored the cognitive and behavioral effects of alcohol and caffeine. Her research portfolio has focused primarily on cognitive impairment and enhancement, alcohol hangover, and drug use and functional outcomes. Sarah aims to disentangle the neurocognitive effects of licit and illicit substances in order to identify relationships between their behavioral effects and pharmacological properties, as well as to reduce dangerous behaviors and harm.

**Andrew Scholey** is Professor of Human Psychopharmacology based in Melbourne, Australia. He is a leading international researcher for the neurocognitive effects of nutritional interventions, recreational drugs, supplements, and food components. He has published >250 peer-reviewed journal articles, as well as over 25 books and book chapters. He has attracted around \$25 million in research funding. Andrew has been a lead investigator on a series of studies regarding human biobehavioral effects of nutritional interventions, focusing on potential neurocognition-enhancing and anti-stress/anxiolytic properties (including first-into-human neurocognitive assessment of ginseng, sage, curcumin, and lemon balm amongst others). His current research focuses on neuroimaging and biomarker techniques to better understand the mechanisms of cognitive enhancement. Andrew works closely with the industry to allow for the rapid translation of research into evidence-based end-user health benefits.

**Ann-Kathrin Stock** (1987) studied psychology and obtained her doctorate at the University of Bochum in 2014, where she focused on dopaminergic modulation of action control. She is currently a senior researcher at the Faculty of Medicine/Chair of Cognitive Neurophysiology and at the Faculty of Psychology/Chair of Biopsychology at TU Dresden, Germany. Dr. Stock's research focuses on neurobiochemical modulators of action control and executive functions. With respect to drugs of abuse, her research focuses on both short- and long-term effects of alcohol and stimulant (ab)use.
